Acquisition of Exclusive Medicines from Lab. Imporquimica for ULSASI for the Year 2026
About This Opportunity
TranslatedThis tender involves the acquisition of exclusive medicines from Lab. Imporquimica specifically for the ULSASI (Unidade Local de Saúde do Alto Sávio) for the year 2026. The procurement aims to ensure the availability of essential medications required for the healthcare services provided by ULSASI. Interested bidders must demonstrate their capability to supply the specified medicines in compliance with the regulatory standards and quality requirements set forth by health authorities. Key requirements include the submission of relevant certifications, adherence to delivery timelines, and the provision of competitive pricing. The tender is open to pharmaceutical companies that can meet the necessary criteria and are able to deliver the products within the stipulated timeframe. This procurement is crucial for maintaining the health services in the region and ensuring that patients have access to the necessary treatments. The location of the services is within the jurisdiction of ULSASI, which serves the local population's healthcare needs. Bidders are encouraged to review the tender documents thoroughly to understand all specifications and requirements before submission.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 17,550.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de Medicamentos Exclusivos, ao Lab. Imporquimica, para a ULSASI, para o ano de 2026" pertains to the procurement of exclusive pharmaceuticals for the Unidade Local de Saúde do Alto Alentejo (ULSASI) in Portugal, specifically for the year 2026.
This procurement initiative is part of the broader efforts to ensure the availability of essential medications within the healthcare system, addressing critical public health needs.
The contracting authority, ULSASI, is responsible for providing comprehensive healthcare services in the Alto Alentejo region, and this tender aims to secure a reliable supply of specialized medications that are vital to patient care. Typical requirements for such a tender include the provision of high-quality pharmaceuticals that meet regulatory standards, timely delivery schedules, and adherence to specific storage and handling protocols to ensure medication efficacy.
Participants in this tender are expected to demonstrate compliance with applicable pharmaceutical regulations, including but not limited to Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP). Additionally, bidders may be required to provide evidence of previous experience in supplying similar products to public healthcare providers, as well as the capacity to meet the projected demand for the specified medications.
This tender represents an important opportunity for pharmaceutical companies to contribute to the healthcare landscape in Portugal, ultimately enhancing patient outcomes through the provision of necessary medical treatments. Interested parties are encouraged to refer to the Portal BASE for further details and submission guidelines.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 23, 2026. Last refreshed 31 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saude Amadora/Sintra, E.P.E.
Unidade Local de Saude Amadora/Sintra, E.P.E. has issued 785 procurement notices on BidsFactory, including 0 currently open and 782 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: July 10, 2026.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to IMPORQUIMICA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saude Amadora/Sintra, E.P.E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €17,550. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.